Actelion is part of the Johnson & Johnson Family of Companies. We are leaders in the science and medicine of pulmonary arterial hypertension (PAH), with over 15 years of experience in this devastating cardiovascular disorder.

Actelion today

Actelion today

Find out more about our marketed products and our clinical development pipeline and how we developed Actelion into a leading company in the field of PAH.

Actelion people

Actelion people

Actelion is highly conscious of the fact that it’s people who make the difference. In turn, we have made sure our employees understand that we expect each of them to make a significant contribution.

Target disease

Target disease

Actelion’s products and late-stage development compounds target a number of different diseases.

Partnerships

Partnerships

Actelion considers sophisticated partnerships to strategically access technologies or products, and to maximize the value of our assets.

Actelion worldwide

Actelion worldwide

Actelion has operative affiliates in over 30 countries - explore our global operations.

"I enjoy working for Actelion because every day we strive to make a difference in people's lives."

Physician, Global Drug Safety